
Berry Genomics Co.,Ltd — Investor Relations & Filings
Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 重大资产重组报告书(草案)及其摘要的修订说明公告 | 2016-12-18 | Chinese | |
| 北京市金杜律师事务所关于公司发行股份购买资产及重大资产出售暨关联交易之补充法律意见书(一) | 2016-12-18 | Chinese | |
| 中信建投证券股份有限公司关于深圳证券交易所《关于对成都天兴仪表股份有限公司的重组问询函》相关问题之专项核查意见 | 2016-12-18 | Chinese | |
| 关于重大资产重组媒体说明会召开情况的公告 | 2016-12-14 | Chinese | |
| 关于召开媒体说明会的提示性公告 | 2016-12-12 | Chinese | |
| 重大资产重组进展公告 | 2016-12-11 | Chinese |
Browse filings by year
27 years- 2026 23 filings
- 2025 83 filings
- 2024 89 filings
- 2023 127 filings
- 2022 106 filings
- 2021 125 filings
- 2020 162 filings
- 2019 112 filings
- 2018 131 filings
- 2017 154 filings
- 2016 161 filings
- 2015 76 filings
- 2014 146 filings
- 2013 52 filings
- 2012 68 filings
- 2011 33 filings
- 2010 44 filings
- 2009 45 filings
- 2008 34 filings
- 2007 52 filings
- 2006 59 filings
- 2005 39 filings
- 2004 18 filings
- 2003 34 filings
- 2002 29 filings
- 2001 5 filings
- 1997 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2016
15 filings
| |||||
| 43217372 | 重大资产重组报告书(草案)及其摘要的修订说明公告 | 2016-12-18 | Chinese | ||
| 43217324 | 北京市金杜律师事务所关于公司发行股份购买资产及重大资产出售暨关联交易之补充法律意见书(一) | 2016-12-18 | Chinese | ||
| 43217269 | 中信建投证券股份有限公司关于深圳证券交易所《关于对成都天兴仪表股份有限公司的重组问询函》相关问题之专项核查意见 | 2016-12-18 | Chinese | ||
| 43217193 | 关于重大资产重组媒体说明会召开情况的公告 | 2016-12-14 | Chinese | ||
| 43217154 | 关于召开媒体说明会的提示性公告 | 2016-12-12 | Chinese | ||
| 43217097 | 重大资产重组进展公告 | 2016-12-11 | Chinese | ||
| 43217059 | 中信建投证券股份有限公司关于公司发行股份购买资产及重大资产出售暨关联交易之独立财务顾问报告 | 2016-12-05 | Chinese | ||
| 43216264 | 拟进行重大资产重组涉及的拟置入的北京贝瑞和康生物技术股份有限公司股东全部权益评估报告书 | 2016-12-04 | Chinese | ||
| 43216092 | 关于公司本次交易摊薄当期每股收益的影响及填补回报安排的公告 | 2016-12-04 | Chinese | ||
| 43216047 | 董事会关于公司股票价格波动未达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的说明 | 2016-12-04 | Chinese | ||
| 43216016 | 简式权益变动报告书(一) | 2016-12-04 | Chinese | ||
| 43215932 | 关于本次重大资产重组涉及控股股东、实际控制人及其他5%以上股东权益变动的提示性公告 | 2016-12-04 | Chinese | ||
| 43215883 | 拟资产出售项目所涉及的指定资产及负债价值资产评估报告 | 2016-12-04 | Chinese | ||
| 43215766 | 关于召开2016年第二次临时股东大会的通知 | 2016-12-04 | Chinese | ||
| 43215726 | 发行股份购买资产及重大资产出售暨关联交易报告书(草案) | 2016-12-04 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Berry Genomics Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53769/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53769 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53769 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53769 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53769}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Berry Genomics Co.,Ltd (id: 53769)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.